Weight Loss with Semaglutide – An Easy STEP?
![](https://www.ceimpact.com/wp-content/uploads/course-images-solidbg/2021/11/preceptor/3998-768x768.jpg)
Weight Loss with Semaglutide – An Easy STEP?
America has a weight problem – over 40% of the US is obese and over 70% are overweight. Diet and exercise are the cornerstones of treatment; however, new medications are coming to the market. The recent STEP Trial evaluated injectable semaglutide for weight loss. This course will evaluate the trial and if there is now an easy step in weight loss.
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
1. Describe the mechanism of action and clinical pearls of semaglutide
2. Compare and contrast semaglutide with other available glucagon-like peptide-1 receptor agonists
3. Discuss clinical trial data on semaglutide’s effect on weight outcomes
4. Identify patients who are candidates to receive semaglutide for weight loss
5. Develop a conclusion for the clinical appropriateness of care based on a clinical trial
Abby Winter, PharmD, MPA, BCACP
Clinical Assistant Professor
University of Washington
Abby Winter does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
Off-label use of medications will be discussed during this course.
To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read:
Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.
Fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: November 10, 2021
Planned Expiration Date: November 10, 2024
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
Duration | 1h 0m |
---|---|
Topic Designator | Disease State/Drug Therapy |
ACPE | Yes |
ACPE Topic | 01 Drug Therapy |
Role | Pharmacist |
Media-Type | On-Demand |
Release Date | 11/10/21 |
CEUs | 0.1 |
Rating | 4 |
ACPE Number | 0107-0000-21-371-H01-P |
This course is in our subscription.
Related products
-
-
COVID-19 Updates: Booster Doses and Pediatric Vaccines [Pharmacist]
In Courses, PharmacistRated 0 out of 5$24.00